1. Home
  2. NEO vs DGII Comparison

NEO vs DGII Comparison

Compare NEO & DGII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NEO
  • DGII
  • Stock Information
  • Founded
  • NEO 2001
  • DGII 1985
  • Country
  • NEO United States
  • DGII United States
  • Employees
  • NEO N/A
  • DGII N/A
  • Industry
  • NEO Precision Instruments
  • DGII Computer peripheral equipment
  • Sector
  • NEO Health Care
  • DGII Technology
  • Exchange
  • NEO Nasdaq
  • DGII Nasdaq
  • Market Cap
  • NEO 1.1B
  • DGII 1.3B
  • IPO Year
  • NEO 1999
  • DGII N/A
  • Fundamental
  • Price
  • NEO $9.15
  • DGII $36.30
  • Analyst Decision
  • NEO Buy
  • DGII Buy
  • Analyst Count
  • NEO 10
  • DGII 4
  • Target Price
  • NEO $12.56
  • DGII $38.75
  • AVG Volume (30 Days)
  • NEO 3.0M
  • DGII 219.1K
  • Earning Date
  • NEO 10-28-2025
  • DGII 11-12-2025
  • Dividend Yield
  • NEO N/A
  • DGII N/A
  • EPS Growth
  • NEO N/A
  • DGII 147.46
  • EPS
  • NEO N/A
  • DGII 1.14
  • Revenue
  • NEO $689,189,000.00
  • DGII $420,935,000.00
  • Revenue This Year
  • NEO $10.40
  • DGII $2.46
  • Revenue Next Year
  • NEO $10.11
  • DGII $7.51
  • P/E Ratio
  • NEO N/A
  • DGII $32.11
  • Revenue Growth
  • NEO 9.70
  • DGII N/A
  • 52 Week Low
  • NEO $4.72
  • DGII $22.39
  • 52 Week High
  • NEO $19.12
  • DGII $38.64
  • Technical
  • Relative Strength Index (RSI)
  • NEO 67.00
  • DGII 47.75
  • Support Level
  • NEO $7.56
  • DGII $35.63
  • Resistance Level
  • NEO $9.24
  • DGII $37.18
  • Average True Range (ATR)
  • NEO 0.36
  • DGII 0.88
  • MACD
  • NEO 0.06
  • DGII -0.24
  • Stochastic Oscillator
  • NEO 92.86
  • DGII 3.28

About NEO NeoGenomics Inc.

NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. It operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.

About DGII Digi International Inc.

Digi International Inc is a Minnesota corporation. The company provides business and mission-critical and Internet of Things (IoT) connectivity products and services. It has two segments: IoT Products and Services and IoT Solutions. The IoT Products and Services segment consists of distinct communications products and communication product development services. IoT Solutions segment offers wireless temperature and other environmental condition monitoring services as well as employee task management services. The company generates majority of its revenue from the IoT Products & Services segment. Geographically, the company generates majority of its revenue from its business in the United States and also has its presence in Europe, Middle East and Africa and Rest of the world.

Share on Social Networks: